O'Malley DM, Bariani GM, Cassier PA, Marabelle A, et al. Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results. Gynecol Oncol 2025;193:130-135.
PMID: 39847999